Medartis Holding AG Logo

Medartis Holding AG

MED | SW

Overview

Corporate Details

ISIN(s):
CH0386200239
LEI:
506700VUSP6HG3F28846
Country:
Switzerland
Address:
Hochbergerstr. 60E, 4057 Basel
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medartis Holding AG is a global medical device company specializing in the development, manufacturing, and distribution of high-precision implants for the surgical fixation of bone fractures. The company provides a comprehensive portfolio of solutions, including titanium screws, plates, and surgical instruments, primarily for osteosynthesis. Its products are used for fractures and corrections in the upper and lower extremities, as well as for craniomaxillofacial surgeries. Medartis serves surgeons, hospitals, and medical centers worldwide, focusing on delivering innovative and technically advanced implants to improve patient outcomes.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Medartis Holding AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-19 06:58
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 58.8 KB
2025-08-19 02:00
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 65.2 KB
2025-08-19 02:00
Earnings Release
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % u…
German 67.9 KB
2025-07-30 09:59
Regulatory News Service
Medartis 2025 half-year results webcast
English 11.1 KB
2025-07-17 06:59
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 11.8 KB
2025-07-17 02:00
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 15.5 KB
2025-07-17 02:00
M&A Activity
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
German 16.3 KB
2025-03-19 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 01:00
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 61.8 KB
2025-03-18 01:00
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
German 63.2 KB
2024-08-20 07:05
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 51.0 KB
2024-08-20 02:00
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 45.2 KB
2024-08-20 02:00
Earnings Release
Medartis verzeichnet ein Umsatzwachstum von 13% auf Gruppenebene, angetrieben d…
German 48.8 KB
2024-07-09 06:59
Board/Management Information
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Medartis Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medartis Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-25 N/A Non-Executive member Buy None 176,411.02 CHF
2025-04-10 N/A Non-Executive member Buy None 37,500.00 CHF
2025-04-08 N/A Non-Executive member Buy None 375,000.00 CHF
2024-12-30 N/A Non-Executive member Buy None 4,999,956.00 CHF
2024-12-20 N/A Executive member Buy None 5,120.00 CHF
2024-12-19 N/A Executive member Buy None 5,300.00 CHF
2024-12-17 N/A Executive member Buy None 16,200.00 CHF
2024-12-16 N/A Executive member Buy None 2,214.00 CHF
2024-12-12 N/A Executive member Buy None 1,188.00 CHF
2024-12-11 N/A Executive member Buy None 72,795.60 CHF

Peer Companies

Company Country Ticker View
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Develops adjustable, minimally invasive implants for structural heart disease and urology.
France AFME
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
A global leader in eye care, offering surgical and vision care products worldwide.
Switzerland ALC
Allmed Solutions Ltd. Logo
Develops and markets advanced, minimally invasive medical products for healthcare professionals globally.
Israel ALMD
Alteco Medical AB Logo
Develops blood purification devices to remove endotoxins from patients with sepsis in intensive care.
Sweden ALTE
Ambu Logo
Develops single-use endoscopes, anaesthesia, and monitoring devices to improve patient safety.
Denmark AMBU
Amplitude Surgical Logo
Develops and markets high-end orthopedic implants for hip and knee pathologies worldwide.
France AMPLI